SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-20-000093
Filing Date
2020-08-06
Accepted
2020-08-06 16:06:00
Documents
17
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant-8xkearningsq2.htm   iXBRL 8-K 42350
2 EXHIBIT 99.1 opntq2earningspressrel.htm EX-99.1 34655
8 opntq2earningspressre_image1.gif GRAPHIC 165617
9 opntq2earningspressre_image2.gif GRAPHIC 191542
  Complete submission text file 0001385508-20-000093.txt   722036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20200806.xsd EX-101.SCH 4426
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20200806_cal.xml EX-101.CAL 604
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20200806_def.xml EX-101.DEF 1454
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20200806_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20200806_pre.xml EX-101.PRE 14094
10 EXTRACTED XBRL INSTANCE DOCUMENT opiant-8xkearningsq2_htm.xml XML 4491
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 201081561
SIC: 1000 Metal Mining